Risk factors for disease progression in the placebo arm of a clinical trial population with idiopathic pulmonary fibrosis

Category Primary study
ConferenceAmerican Journal of Respiratory and Critical Care Medicine
Year 2017
This article has no abstract
Epistemonikos ID: 15185ef7e5d843bb9a2a725e967264e4aca08adf
First added on: Apr 29, 2026